Nothing Special   »   [go: up one dir, main page]

Pilot et al., 2018 - Google Patents

Buffer therapy→ buffer diet

Pilot et al., 2018

View PDF
Document ID
6477459599631352565
Author
Pilot C
Mahipal A
Gillies R
Publication year
Publication venue
J. Nutr. Food Sci

External Links

Snippet

Malignant tumors exhibit an increase in glucose metabolism when compared to normal tissue. The increased metabolism generates an acidic tumor environment, which promotes local invasion, metastasis, and inhibition of immune surveillance. Oral buffers, eg 200 mM …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Pilot et al. Buffer therapy→ buffer diet
Lönnerdal Dietary factors influencing zinc absorption
Bryan et al. The role of nitrate in human health
Hoppe et al. Probiotic strain Lactobacillus plantarum 299v increases iron absorption from an iron-supplemented fruit drink: a double-isotope cross-over single-blind study in women of reproductive age
Cámara et al. Nutrional aspect of zinc availability
US9375451B2 (en) Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
Wyskida et al. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease
Ribeiro et al. Buffer Therapy for Cancer.
Baker Nutritional anaemia—a major controllable public health problem
Buchowski Calcium in the context of dietary sources and metabolism
US9597308B2 (en) N-acetyl L-cysteine chelates and methods for making and using the same
Willmott et al. Does the oral microbiome play a role in hypertensive pregnancies?
EP0265505A1 (en) Use of iron (iii) phosphate compounds for iron fortification of food products, a method of preparing iron-fortified food products and the iron-fortified food products.
US20200022944A1 (en) Composition or medical food to extract the dietary iron and boost its bioavailability for iron deficiency (id) and id-anemia
JPS58165742A (en) Nutritive composition for infant
JP5546900B2 (en) Panaxatriol stabilizing composition
Maria de Lourdes et al. Buffer therapy for cancer
CA2922396C (en) N-acetyl l-cysteine chelates and methods for making and using the same
Nair et al. Strategies to combat anaemia
Moscheo et al. New Insights into Iron Deficiency Anemia in Children: A Practical Review. Metabolites 2022, 12, 289
Kim et al. Relationships between faecal phytate and mineral excretion depend on dietary phytate and age
Alpers Intraluminal bioavailability of divalent cations
Giorgetti PREVENTION AND TREATMENT OF IRON DEFICIENCY ANEMIA IN WOMEN AND CHILDREN: IRON HOMEOSTASIS AND OPTIMIZING ABSORPTION USING PREBIOTICS AND BREAST MILK COMPONENTS
JP2011173850A (en) Stabilized panaxadiol composition
NUTA et al. Victoria-Madalina MIHAESCU", Raluca-Ioana DASCALU"